Launching with $300 million in hand, Kardigan plans to develop parallel treatments to prevent and cure cardiovascular diseases so that they’re no longer the leading cause of death worldwide ...
SAN FRANCISCO & PRINCETON, N.J., January 10, 2025--(BUSINESS WIRE)--Kardigan, a heart health company modernizing cardiovascular drug development, launched today with a mission to develop multiple ...
“At Kardigan, we are bringing together a world-class team of experts to think differently with a singular focus to deliver multiple important medicines at an unprecedented rate. Our cardiac ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback